These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 36481938)
1. Loss of KDM5B ameliorates pathological cardiac fibrosis and dysfunction by epigenetically enhancing ATF3 expression. Wang B; Tan Y; Zhang Y; Zhang S; Duan X; Jiang Y; Li T; Zhou Q; Liu X; Zhan Z Exp Mol Med; 2022 Dec; 54(12):2175-2187. PubMed ID: 36481938 [TBL] [Abstract][Full Text] [Related]
2. Loss of BTK ameliorates the pathological cardiac fibrosis and dysfunction. Wang B; Tan Y; Zhou W; Yang J; Jiang Y; Liu X; Zhan Z Matrix Biol; 2022 Sep; 112():171-189. PubMed ID: 36031013 [TBL] [Abstract][Full Text] [Related]
3. Cardiac Fibroblast-Specific Activating Transcription Factor 3 Protects Against Heart Failure by Suppressing MAP2K3-p38 Signaling. Li Y; Li Z; Zhang C; Li P; Wu Y; Wang C; Bond Lau W; Ma XL; Du J Circulation; 2017 May; 135(21):2041-2057. PubMed ID: 28249877 [TBL] [Abstract][Full Text] [Related]
4. Histone demethylase KDM5B is a key regulator of genome stability. Li X; Liu L; Yang S; Song N; Zhou X; Gao J; Yu N; Shan L; Wang Q; Liang J; Xuan C; Wang Y; Shang Y; Shi L Proc Natl Acad Sci U S A; 2014 May; 111(19):7096-101. PubMed ID: 24778210 [TBL] [Abstract][Full Text] [Related]
5. Histone demethylase lysine demethylase 5B in development and cancer. Han M; Xu W; Cheng P; Jin H; Wang X Oncotarget; 2017 Jan; 8(5):8980-8991. PubMed ID: 27974677 [TBL] [Abstract][Full Text] [Related]
6. The PHD1 finger of KDM5B recognizes unmodified H3K4 during the demethylation of histone H3K4me2/3 by KDM5B. Zhang Y; Yang H; Guo X; Rong N; Song Y; Xu Y; Lan W; Zhang X; Liu M; Xu Y; Cao C Protein Cell; 2014 Nov; 5(11):837-50. PubMed ID: 24952722 [TBL] [Abstract][Full Text] [Related]
7. SUMOylation negatively modulates target gene occupancy of the KDM5B, a histone lysine demethylase. Bueno MT; Richard S Epigenetics; 2013 Nov; 8(11):1162-75. PubMed ID: 23970103 [TBL] [Abstract][Full Text] [Related]
8. KDM5B demethylates H3K4 to recruit XRCC1 and promote chemoresistance. Xu W; Zhou B; Zhao X; Zhu L; Xu J; Jiang Z; Chen D; Wei Q; Han M; Feng L; Wang S; Wang X; Zhou J; Jin H Int J Biol Sci; 2018; 14(9):1122-1132. PubMed ID: 29989047 [TBL] [Abstract][Full Text] [Related]
9. Discovery of Novel Pyrazole-Based KDM5B Inhibitor Tang K; Jiao LM; Qi YR; Wang TC; Li YL; Xu JL; Wang ZW; Yu B; Liu HM; Zhao W J Med Chem; 2022 Oct; 65(19):12979-13000. PubMed ID: 36112701 [TBL] [Abstract][Full Text] [Related]
10. The histone-H3K4-specific demethylase KDM5B binds to its substrate and product through distinct PHD fingers. Klein BJ; Piao L; Xi Y; Rincon-Arano H; Rothbart SB; Peng D; Wen H; Larson C; Zhang X; Zheng X; Cortazar MA; Peña PV; Mangan A; Bentley DL; Strahl BD; Groudine M; Li W; Shi X; Kutateladze TG Cell Rep; 2014 Jan; 6(2):325-35. PubMed ID: 24412361 [TBL] [Abstract][Full Text] [Related]
11. KDM5B histone demethylase controls epithelial-mesenchymal transition of cancer cells by regulating the expression of the microRNA-200 family. Enkhbaatar Z; Terashima M; Oktyabri D; Tange S; Ishimura A; Yano S; Suzuki T Cell Cycle; 2013 Jul; 12(13):2100-12. PubMed ID: 23759590 [TBL] [Abstract][Full Text] [Related]
12. Studies of H3K4me3 demethylation by KDM5B/Jarid1B/PLU1 reveals strong substrate recognition in vitro and identifies 2,4-pyridine-dicarboxylic acid as an in vitro and in cell inhibitor. Kristensen LH; Nielsen AL; Helgstrand C; Lees M; Cloos P; Kastrup JS; Helin K; Olsen L; Gajhede M FEBS J; 2012 Jun; 279(11):1905-14. PubMed ID: 22420752 [TBL] [Abstract][Full Text] [Related]
13. Lysine demethylase 5B (KDM5B): A potential anti-cancer drug target. Zheng YC; Chang J; Wang LC; Ren HM; Pang JR; Liu HM Eur J Med Chem; 2019 Jan; 161():131-140. PubMed ID: 30343192 [TBL] [Abstract][Full Text] [Related]
14. KDM5B is a master regulator of the H3K4-methylome in stem cells, development and cancer. Xhabija B; Kidder BL Semin Cancer Biol; 2019 Aug; 57():79-85. PubMed ID: 30448242 [TBL] [Abstract][Full Text] [Related]
15. KDM5B Is Essential for the Hyperactivation of PI3K/AKT Signaling in Prostate Tumorigenesis. Li G; Kanagasabai T; Lu W; Zou MR; Zhang SM; Celada SI; Izban MG; Liu Q; Lu T; Ballard BR; Zhou X; Adunyah SE; Matusik RJ; Yan Q; Chen Z Cancer Res; 2020 Nov; 80(21):4633-4643. PubMed ID: 32868382 [TBL] [Abstract][Full Text] [Related]
16. Induction of activating transcription factor 3 limits survival following infarct-induced heart failure in mice. Brooks AC; DeMartino AM; Brainard RE; Brittian KR; Bhatnagar A; Jones SP Am J Physiol Heart Circ Physiol; 2015 Oct; 309(8):H1326-35. PubMed ID: 26342068 [TBL] [Abstract][Full Text] [Related]
17. Histone lysine demethylase KDM5B maintains chronic myeloid leukemia via multiple epigenetic actions. Xue S; Lam YM; He Z; Zheng Y; Li L; Zhang Y; Li C; Mbadhi MN; Zheng L; Cheng Z; Liu Y; Wang X; Chan LC; Ng RK; Zhang J Exp Hematol; 2020 Feb; 82():53-65. PubMed ID: 32007477 [TBL] [Abstract][Full Text] [Related]
18. KDM5B protein expressed in viable and fertile ΔARID mice exhibit no demethylase activity. Jamshidi S; Catchpole S; Chen J; So CWE; Burchell J; Rahman KM; Taylor-Papadimitriou J Int J Oncol; 2021 Nov; 59(5):. PubMed ID: 34713299 [TBL] [Abstract][Full Text] [Related]
19. Coordinated regulation of retinoic acid signaling pathway by KDM5B and polycomb repressive complex 2. Zhang Y; Liang J; Li Q J Cell Biochem; 2014 Sep; 115(9):1528-38. PubMed ID: 24619877 [TBL] [Abstract][Full Text] [Related]
20. Lysine demethylase KDM5B down-regulates SIRT3-mediated mitochondrial glucose and lipid metabolism in diabetic neuropathy. Jiao Y; Li YZ; Zhang YH; Cui W; Li Q; Xie KL; Yu Y; Yu YH Diabet Med; 2023 Jan; 40(1):e14964. PubMed ID: 36130801 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]